Etzer Darout
Stock Analyst at Barclays
Total Price Targets
48
Stocks Covered
21
Sectors
Healthcare
Most Recent
Mar 9, 2026
Notable Calls (Last 12 Months)
Most Bullish
Stocks Covered by Etzer Darout
| Symbol | Company | Latest Target | Current Price | Upside | # Targets | Last Updated |
|---|---|---|---|---|---|---|
| JAZZ | Jazz Pharmaceuticals plc | $224.00 | $202.38 | +10.7% | 1 | Mar 9, 2026 |
| SRRK | Scholar Rock Holding Corporation | $53.00 | $46.75 | +13.4% | 7 | Mar 3, 2026 |
| CCCC | C4 Therapeutics, Inc. | $7.00 | $2.90 | +141.0% | 3 | Feb 26, 2026 |
| EXEL | Exelixis, Inc. | $44.00 | $43.81 | +0.4% | 3 | Feb 4, 2026 |
| VIR | Vir Biotechnology, Inc. | $24.00 | $10.02 | +139.6% | 1 | Feb 4, 2026 |
| CTMX | CytomX Therapeutics, Inc. | $8.00 | $4.16 | +92.5% | 7 | Jan 20, 2026 |
| ANAB | AnaptysBio, Inc. | $55.00 | $66.67 | -17.5% | 1 | Dec 17, 2025 |
| SMMT | Summit Therapeutics Inc. | $18.00 | $16.11 | +11.7% | 1 | Dec 17, 2025 |
| TERN | Terns Pharmaceuticals, Inc. | $56.00 | $52.94 | +5.8% | 5 | Dec 9, 2025 |
| KURA | Kura Oncology, Inc. | $28.00 | $8.80 | +218.0% | 1 | Nov 24, 2025 |
| NUVL | Nuvalent, Inc. | $152.00 | $99.45 | +52.8% | 2 | Nov 17, 2025 |
| XNCR | Xencor, Inc. | $23.00 | $12.88 | +78.6% | 2 | Oct 29, 2025 |
| MNPR | Monopar Therapeutics Inc. | $125.00 | $53.02 | +135.8% | 1 | Oct 13, 2025 |
| ARVN | Arvinas, Inc. | $20.00 | $10.55 | +89.5% | 1 | Mar 12, 2025 |
| KYMR | Kymera Therapeutics, Inc. | $55.00 | $81.54 | -32.5% | 1 | Dec 5, 2024 |
| NRIX | Nurix Therapeutics, Inc. | $35.00 | $16.83 | +108.0% | 1 | Dec 5, 2024 |
| PTGX | Protagonist Therapeutics, Inc. | $62.00 | $98.16 | -36.8% | 1 | Dec 5, 2024 |
| ACRV | Acrivon Therapeutics, Inc. Common Stock | $27.00 | $2.05 | +1217.1% | 3 | Nov 14, 2024 |
| FATE | Fate Therapeutics, Inc. | $5.00 | $1.55 | +221.5% | 2 | Nov 13, 2024 |
| AZN | AstraZeneca PLC | $176.00 | $185.21 | -5.0% | 3 | Nov 13, 2024 |
| MGNX | MacroGenics, Inc. | $8.00 | $3.16 | +153.2% | 1 | May 10, 2024 |
Recent Activity
- Mar 9, 2026— Set$224.00price target onJAZZ(Jazz Pharmaceuticals plc)
- Mar 3, 2026— Set$53.00price target onSRRK(Scholar Rock Holding Corporation)
- Feb 26, 2026— Set$7.00price target onCCCC(C4 Therapeutics, Inc.)
- Feb 4, 2026— Set$44.00price target onEXEL(Exelixis, Inc.)
- Feb 4, 2026— Set$24.00price target onVIR(Vir Biotechnology, Inc.)
- Jan 20, 2026— Set$8.00price target onCTMX(CytomX Therapeutics, Inc.)
- Dec 17, 2025— Set$18.00price target onSMMT(Summit Therapeutics Inc.)
- Dec 17, 2025— Set$55.00price target onANAB(AnaptysBio, Inc.)
- Dec 17, 2025— Set$52.00price target onSRRK(Scholar Rock Holding Corporation)
- Dec 9, 2025— Set$56.00price target onTERN(Terns Pharmaceuticals, Inc.)
- Nov 25, 2025— Set$36.00price target onTERN(Terns Pharmaceuticals, Inc.)
- Nov 24, 2025— Set$28.00price target onKURA(Kura Oncology, Inc.)
- Nov 17, 2025— Set$152.00price target onNUVL(Nuvalent, Inc.)
- Nov 5, 2025— Set$41.00price target onEXEL(Exelixis, Inc.)
- Oct 29, 2025— Set$23.00price target onXNCR(Xencor, Inc.)
- Oct 22, 2025— Set$14.00price target onTERN(Terns Pharmaceuticals, Inc.)
- Oct 21, 2025— Set$6.00price target onCTMX(CytomX Therapeutics, Inc.)
- Oct 13, 2025— Set$125.00price target onMNPR(Monopar Therapeutics Inc.)
- Sep 24, 2025— Set$44.00price target onSRRK(Scholar Rock Holding Corporation)
- Sep 22, 2025— Set$10.00price target onCCCC(C4 Therapeutics, Inc.)
Frequently Asked Questions
Who is Etzer Darout?
Etzer Darout is a stock analyst at Barclays covering 21 stocks primarily in Healthcare. They have issued 48 price targets since Mar 12, 2024.
What stocks does Etzer Darout cover?
Etzer Darout currently covers 21 stocks, including SRRK, CTMX, TERN, CCCC, EXEL.
What is Etzer Darout's latest price target?
Etzer Darout's most recent price target was $224.00 on JAZZ (Jazz Pharmaceuticals plc), set on Mar 9, 2026.
What is Etzer Darout's highest price target?
Etzer Darout's highest issued price target is $224.00 on JAZZ, set on Mar 9, 2026.
More Analysts at Barclays
Coverage based on publicly published price targets. Not investment advice.